Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-25 @ 9:52 PM
Study NCT ID:
NCT00330551
Status:
COMPLETED
Last Update Posted:
2023-03-01
First Post:
2006-05-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
Sponsor:
University of California, Los Angeles
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2012-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-26
First Submit QC Date:
None
Study First Post Date:
2006-05-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-02
Results First Submit QC Date:
None
Results First Post Date:
2020-03-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-04
Last Update Post Date:
2023-03-01
Last Update Post Date Type:
ACTUAL